SynBioBeta 2026 is a global conference on AI and synthetic biology taking place May 4 to 7 in San Jose, California, bringing together founders, investors, biopharma leaders, startups, and corporates building and commercializing bio-based technologies. The event is designed as a business-focused platform where companies developing areas like programmable RNA, AI-driven drug discovery, enzymes, and novel proteins can connect directly with partners, customers, and capital, with a strong emphasis on deal-making through curated networking, startup showcases, and pre-scheduled 1:1 meetings.